Articles by Christie M. Ballantyne (22)

Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study

Christie M. Ballantyne, Michael H. Davidson, James M. McKenney, Laurence H. Keller, Daiva R. Bajorunas and Richard H. Karas

Journal of Clinical Lipidology 2 ( 2 ): 79 - 90 , 2008

Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses

Nicola Abate, Alberico L. Catapano, Christie M. Ballantyne, Michael H. Davidson, Adam Polis, Steven S. Smugar and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 2 ): 91 - 105 , 2008

Efficacy and Safety of Multi-drug Therapy for Hypertriglceridemia

Venkat Polsani, Christie M. Ballantyne, Peter H. Jones, Vijay Nambi, Salim S. Virani and Daniele Zoch

Journal of Clinical Lipidology 2 ( 3 ): 204 - 205 , 2008

Is Obesity an Independent Predictor of Post-operative Renal Insufficiency?

Salim S. Virani, Mahboob Alam, Christie M. Ballantyne, McArthur A. Elayda, Vei-Vei Lee, Vijay Nambi, Wei Pan, Venkatesh Polsani and James M. Wilson

Journal of Clinical Lipidology 2 ( 3 ): 205 - 206 , 2008

Effects of Niacin Extended-Release/Simvastatin Versus Simvastatin Monotherapy on Plasma Lipids in Patients with or without High Baseline Triglycerides

Richard H. Karas, Daiva R. Bajorunas, Christie M. Ballantyne, Michael H. Davidson, Laurence H. Keller, James McKenney, Robert J. Padley and Roopal B. Thakkar

Journal of Clinical Lipidology 2 ( 3 ): 220 - 221 , 2008

Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein

Michael H. Davidson, Nicola Abate, Christie M. Ballantyne, Alberico L. Catapano, Xia Xu, Jianxin Lin, Elizabeth Rosenberg and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 6 ): 436 - 446 , 2008

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

Michael H. Davidson, Kevin C. Maki, Harold Bays, Roderick Carter and Christie M. Ballantyne

Journal of Clinical Lipidology 3 ( 5 ): 332 - 340 , 2009

Safety of extended-release niacin/laropiprant in patients with dyslipidemia

James McKenney, Harold Bays, Michael Koren, Christie M. Ballantyne, John F. Paolini, Yale Mitchel, Abigaile Betteridge, Olga Kuznetsova, Aditi Sapre, Christine McCrary Sisk and Darbie Maccubbin

Journal of Clinical Lipidology 4 ( 2 ): 105 - 112 , 2010

Insights from recent meta-analysis: Role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression

Smita Negi and Christie M. Ballantyne

Journal of Clinical Lipidology 4 ( 5 ): 365 - 370 , 2010

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Anne C. Goldberg, Paul N. Hopkins, Peter P. Toth, Christie M. Ballantyne, Daniel J. Rader, Jennifer G. Robinson, Stephen R. Daniels, Samuel S. Gidding, Sarah D. de Ferranti, Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty, William C. Cromwell, Joyce L. Ross and Paul E. Ziajka

Journal of Clinical Lipidology 5 ( 3 ): 133 - 140 , 2011

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W. Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki and Mary R. Dicklin

Journal of Clinical Lipidology 5 ( 5 ): 338 - 367 , 2011

Efficacy and tolerability of multidrug therapy for hypertriglyceridemia

Venkateshwar R. Polsani, Vijay Nambi, Salim S. Virani, Daniele Zoch, Eric Y. Yang, Peter H. Jones and Christie M. Ballantyne

Journal of Clinical Lipidology 3 ( 5 ): 341 - 344 , 2009

Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥2 mg/L)

Christie M. Ballantyne, Michael H. Davidson, Carolyn M. Setze and Maureen T. Kelly

Journal of Clinical Lipidology 5 ( 5 ): 401 - 407 , 2011

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

Jennifer G. Robinson, Christie M. Ballantyne, Willa Hsueh, Jeffrey Rosen, Jianxin Lin, Arvind Shah, Robert S. Lowe, Mary E. Hanson and Andrew M. Tershakovec

Journal of Clinical Lipidology 5 ( 6 ): 474 - 482 , 2011

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction

Peter P. Toth, Christie M. Ballantyne, Michael H. Davidson, Joanne E. Tomassini, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, X. Henry Hu and Kaan Tunceli

Journal of Clinical Lipidology 6 ( 2 ): 180 - 191 , 2012

Statin Therapy Alters the Relationship Between Apolipoprotein B and Both LDL-C and Non-HDL-C in High-Risk Patients: Effect of Race/Ethnic Background

Christie M. Ballantyne, Stephen J. Nicholls, Philip J. Barter, Valerie A. Cain and Joel S. Raichlen

Journal of Clinical Lipidology 6 ( 3 ): 272 - 273 , 2012

Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)

Harold E. Bays, Rene A. Braeckman, Christie M. Ballantyne, John J. Kastelein, James D. Otvos, William G. Stirtan and Paresh N. Soni

Journal of Clinical Lipidology 6 ( 6 ): 565 - 572 , 2012

A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease

Smita I. Negi, Ariel Brautbar, Salim S. Virani, Aashish Anand, Eliana Polisecki, Bela F. Asztalos, Christie M. Ballantyne, Ernst J. Schaefer and Peter H. Jones

Journal of Clinical Lipidology 7 ( 1 ): 82 - 87 , 2013

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome

Jennifer G. Robinson, Christie M. Ballantyne, Willa A. Hsueh, Jeffrey B. Rosen, Jianxin Lin, Arvind K. Shah, Joanne E. Tomassini, Robert S. Lowe and Andrew M. Tershakovec

Journal of Clinical Lipidology 7 ( 4 ): 292 - 303 , 2013

Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome

Madhuri Vasudevan, Urbain Tchoua, Baiba K. Gillard, Peter H. Jones, Christie M. Ballantyne and Henry J. Pownall

Journal of Clinical Lipidology 7 ( 6 ): 661 - 670 , 2013

Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training

Smita I. Negi, Lynne Steinberg, Venkateshwar R. Polsani, Saqib A. Gowani, Vijay Nambi, Varinder Kumar, Victor Marinescu, Peter H. Jones, Laura A. Petersen, Christie M. Ballantyne and Salim S. Virani

Journal of Clinical Lipidology 6 ( 1 ): 50 - 57 , 2012

Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care

Salim S. Virani, Degang Wang, LeChauncy D. Woodard, Supicha S. Chitwood, Cassie R. Landrum, Franklin J. Zieve, Christie M. Ballantyne and Laura A. Petersen

Journal of Clinical Lipidology 6 ( 6 ): 545 - 552 , 2012

Do you have a suggestion for journals

Suggest Journal